Berberine (as Berberine HCl) — 500 mg Berberine HCl is the hydrochloride salt form of berberine — a naturally occurring isoquinoline alkaloid found in the roots and bark of Berberis aristata, Coptis chinensis, and related plants — representing one of the most clinically investigated botanical compounds for cardiometabolic support, with a substantial peer-reviewed human trial portfolio encompassing blood glucose regulation, lipid management, cardiovascular protection, gut microbiome modulation, and GLP-1 secretion support. Berberine's primary metabolic mechanism involves activation of AMP-activated protein kinase (AMPK) — the cellular energy-sensing master kinase that promotes glucose uptake in skeletal muscle and adipose tissue, supports mitochondrial biogenesis, and improves insulin receptor post-receptor signaling sensitivity — while simultaneously protecting and stimulating intestinal L-cells responsible for GLP-1 secretion, directly increasing the endogenous release of this appetite- and glucose-regulatory hormone into the gut lumen. Berberine's gut microbiome-modulating activity — selectively promoting beneficial Lactobacillus and Bifidobacterium populations while suppressing pathogenic bacterial overgrowth — supports the intestinal microbial environment that underpins GLP-1 production capacity, glucose metabolism efficiency, and intestinal barrier integrity, establishing berberine as a uniquely multi-mechanistic single ingredient capable of addressing the cardiometabolic cluster simultaneously.
LeucoSelect® Phytosome — 50 mg LeucoSelect® Phytosome is a patented, bioavailability-enhanced grape seed extract (Vitis vinifera) formulated as a phytosome complex by Indena SpA — molecularly binding the extract's oligomeric proanthocyanidins (OPCs) to phosphatidylcholine to create a lipid-compatible structure that dramatically improves gastrointestinal absorption compared to unformulated grape seed extract. Within the context of this formula, LeucoSelect® provides two clinically relevant activities: first, independent GLP-1 secretion support that operates even in the setting of a suboptimal diet — stimulating intestinal L-cell GLP-1 release to promote satiety and post-meal fullness independently of dietary composition; and second, cardiovascular antioxidant protection through its highly bioavailable OPC content, supporting endothelial integrity, LDL oxidation resistance, capillary vascular health, and healthy inflammatory balance in cardiometabolic tissue. The phytosome delivery technology ensures that the OPC content reaches systemic circulation at concentrations sufficient to provide these cardiometabolic benefits — a clinical distinction not achievable with standard grape seed extract at comparable doses.
R-Alpha Lipoic Acid — 25 mg R-Alpha Lipoic Acid is the biologically active, naturally occurring enantiomer of alpha-lipoic acid — the form preferentially produced endogenously and utilized in mitochondrial enzyme complexes — offering superior antioxidant activity and metabolic cofactor efficacy compared to the racemic DL-ALA mixture in most standard formulations. Within this cardiometabolic formula, R-ALA supports healthy blood pressure regulation through its activity on vascular endothelial nitric oxide synthase, promotes HDL cholesterol production through its influence on reverse cholesterol transport pathways, helps maintain blood glucose within normal ranges through GLUT4 transporter upregulation and insulin receptor sensitization in peripheral tissue, and provides dual-soluble (both aqueous and lipid) free radical scavenging protection across the vascular and metabolic cellular compartments most vulnerable to oxidative damage in cardiometabolic dysfunction. Its glutathione-regenerating activity further amplifies the formula's overall antioxidant network alongside the OPC antioxidant content of LeucoSelect® Phytosome.
Folate (as L-Methyltetrahydrofolate Calcium) — 200 mcg DFE L-Methyltetrahydrofolate Calcium (L-MTHF) is the calcium salt of the predominant active form of folate in human plasma — delivered here in its immediately utilizable coenzyme form that bypasses the MTHFR enzyme conversion step required by standard folic acid, ensuring reliable folate activity independent of individual enzymatic conversion capacity or MTHFR polymorphism status. Within the cardiometabolic context of this formula, L-MTHF serves as the direct methyl donor for homocysteine remethylation via methionine synthase — working in parallel with Berberine's homocysteine-modulating activity to help maintain healthy homocysteine levels within the normal cardiovascular risk range, since elevated homocysteine is an independent cardiovascular risk factor associated with endothelial damage, thrombotic tendency, and vascular inflammation. L-MTHF additionally supports cognitive function, digestive comfort, and may contribute to insulin sensitivity and blood sugar balance through its methyl group donation to the one-carbon metabolic cycle governing neurotransmitter synthesis, DNA methylation, and cellular energy metabolism.
